HEIDI ESSIG: Open Payments
NPI 1265547137 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,659 in 128 payments from 17 companies in 2025. Trend: 2023 $1,419 · 2024 $1,973 · 2025 $2,659
Food & beverage: $2,650Education: $10
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $443 |
| Regeneron Healthcare Solutions, Inc. | 13 | $355 |
| ABBVIE INC. | 19 | $285 |
| LEO Pharma Inc. | 9 | $274 |
| Organon LLC | 14 | $259 |
| Arcutis Biotherapeutics, Inc. | 7 | $155 |
| Janssen Biotech, Inc. | 11 | $154 |
| GENZYME CORPORATION | 3 | $137 |
| Galderma Laboratories, L.P. | 16 | $137 |
| Amgen Inc. | 5 | $98 |
Products named: DUPIXENT, COSENTYX, ANZUPGO, VTAMA, Zoryve, TREMFYA, SKYRIZI, NEMLUVIO.
Industry payments across AL — which companies pay providers there.
